Agilent Completes Acquisition of Proscia
recent articles
Agilent: Expands Agilent’s pathology portfolio and establishes a platform for scientific intelligence in tissue-based precision medicine Strengthens Agilent’s ability to support customers across clinical diagnostics, biopharma and...
From the Proscia blog: Labs now expect their digital pathology platform to offer a broad range of AI applications from multiple vendors. But access alone isn’t enough. The platform also shapes how pathologists, scientists, and lab teams...
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced U.S. commercial availability of the HyperVue Integrated System [1], a new single room-based configuration of its...
From Indica Labs: As a leading provider of laboratory services in genomics, multiomics and healthcare diagnostics, Source BioScience is leveraging large-scale digital pathology to support over 90 partner NHS trusts. Interoperability and...
From Diagnexia on LinkedIn: Delighted to share that Diagnexia has been shortlisted for Health Tech Product of the Year at the LaingBuisson Awards 2026. A huge congratulations to our incredible team and partners for driving innovation and...
From Indica Labs: For researchers using in situ hybridization, optimization of both probing conditions and the analysis approach is necessary for the clearest results, yet the process of identifying the best values can be time consuming....
